MSK Kids is the pediatric oncology and cancer program at Memorial Sloan Kettering Cancer Center, and one of the largest pediatric cancer programs in the country, treating children, teenagers and young adults with cancer and blood disorders. MSK Kids ranked 11th in the nation for pediatric cancer on U.S. News & World Report‘s 2025-26 “Best Children’s Hospitals” list. Through its pediatric translational medicine program, specialists match patients with treatments based on a tumor’s genetic blueprint, while the clinical genetics service and pediatric cancer predisposition screening program assess how genetics factors into a child’s diagnosis and whether other family members may be affected. The Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers is a dedicated clinical and research center focused on improving outcomes for adolescents and young adults with cancer. The Tow Center for Developmental Oncology develops new treatments for cancers in children and young adults, while the Stavros Niarchos Foundation Global Pediatric Cancer Program partners with institutions worldwide to reduce disparities and expand access to high-quality pediatric cancer care globally. Through the New York City Department of Education’s hospital schools program, MSK Kids provides full-time teachers for patients from pre-kindergarten through high school, so children can continue coursework during treatment.
